PANews reported on December 25th that HodlHer announced the completion of a $1.5 million strategic funding round, with investors including Chain Capital, BitrisePANews reported on December 25th that HodlHer announced the completion of a $1.5 million strategic funding round, with investors including Chain Capital, Bitrise

HodlHer, an injective ecosystem platform, has raised $1.5 million in funding to develop an AI-driven Web3 operating system.

2025/12/25 23:35

PANews reported on December 25th that HodlHer announced the completion of a $1.5 million strategic funding round, with investors including Chain Capital, Bitrise Capital, and CGV. HodlHer is the first AI-driven Web3 operating system based on the L1 project Injective. Its core technology, "HodlOS," integrates emotion perception, long-term memory, and decentralized execution, aiming to provide users with a unified experience from information interaction to on-chain operations.

Currently, HodlHer has launched the emotion trading assistant "Sola" and plans to accelerate the development of the multi-agent assistant system "Super InternX" and the decentralized intelligent agent market "Agent Market," supporting users to create and trade personalized AI agents. HodlHer's long-term vision is to become the core operating system of the "personality economy" in the Web3 era, promoting the collaborative symbiosis between humans and AI agents.

Market Opportunity
1 Logo
1 Price(1)
$0.007611
$0.007611$0.007611
+0.22%
USD
1 (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.